TY - JOUR
T1 - Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection
T2 - a prospective cohort study
AU - the RECoVERED Study Group
AU - Verveen, Anouk
AU - Wynberg, Elke
AU - van Willigen, Hugo D.G.
AU - Davidovich, Udi
AU - Lok, Anja
AU - Moll van Charante, Eric P.
AU - de Jong, Menno D.
AU - de Bree, Godelieve
AU - Prins, Maria
AU - Knoop, Hans
AU - Nieuwkerk, Pythia T.
AU - Agard, Ivette
AU - Ayal, Jane
AU - Cavdar, Floor
AU - Craanen, Marianne
AU - Deuring, Annemarieke
AU - van Dijk, Annelies
AU - Ersan, Ertan
AU - del Grande, Laura
AU - Hartman, Joost
AU - Koedoot, Nelleke
AU - Leenstra, Tjalling
AU - Lebbink, Romy
AU - Loomans, Dominique
AU - Makowska, Agata
AU - du Maine, Tom
AU - de Man, Ilja
AU - Matser, Amy
AU - van der Meij, Lizenka
AU - van Polanen, Marleen
AU - Oud, Maria
AU - Reid, Clark
AU - Storey, Leeann
AU - van Wijk, Marc
AU - van den Aardweg, Joost
AU - van Assem, Joyce
AU - van Beek, Marijne
AU - Blankert, Thyra
AU - Dijkstra, Maartje
AU - Figaroa, Orlane
AU - Frenkel, Leah
AU - van Gils, Marit
AU - van Haga, Jelle
AU - Han, Xiaochuan Alvin
AU - Harskamp-Holwerda, Agnes
AU - Hazenberg, Mette
AU - Hidad, Soemeja
AU - de Jong, Nina
AU - Kootstra, Neeltje
AU - Kuijt, Lara
AU - van der Veen, Annelou
AU - Verkaik, Bas
AU - RECoVERED Study Group
N1 - Funding Information: This publication is part of the project “Long-term mental health trajectories in recovered COVID-19 patients: exploring the interplay of psychosocial and biological factors affecting health-related quality of life” with project number 10430032010010 of the research programme COVID-19, financed by the Netherlands Organisation for Health Research and Development (ZonMw). It was embedded in the project RECoVERED with project number 10150062010002 of the research programme Infectieziektebestrijding 3 2019-2023, also financed by ZonMw. This work was additionally supported by the Public Health Service of Amsterdam [Research & Development grant number 21-14]. H.K. received additional funding from “ReCOVer: A Randomised Controlled Trial testing the efficacy of Cognitive Behavioural Therapy for preventing chronic post-infectious fatigue among patients diagnosed with COVID-19” with project number 10430012010025 of the research programme COVID-19, financed by ZonMw. Publisher Copyright: © 2022, The Author(s).
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Background: Currently, there is limited evidence about the long-term impact on physical, social and emotional functioning, i.e. health-related quality of life (HRQL) after mild or moderate COVID-19 not requiring hospitalization. We compared HRQL among persons with initial mild, moderate or severe/critical COVID-19 at 1 and 12 months following illness onset with Dutch population norms and investigated the impact of restrictive public health control measures on HRQL. Methods: RECoVERED, a prospective cohort study in Amsterdam, the Netherlands, enrolled adult participants after confirmed SARS-CoV-2 diagnosis. HRQL was assessed with the Medical Outcomes Study Short Form 36-item health survey (SF-36). SF-36 scores were converted to standard scores based on an age- and sex-matched representative reference sample of the Dutch population. Differences in HRQL over time were compared among persons with initial mild, moderate or severe/critical COVID-19 using mixed linear models adjusted for potential confounders. Results: By December 2021, 349 persons were enrolled of whom 269 completed at least one SF-36 form (77%). One month after illness onset, HRQL was significantly below population norms on all SF-36 domains except general health and bodily pain among persons with mild COVID-19. After 12 months, persons with mild COVID-19 had HRQL within population norms, whereas persons with moderate or severe/critical COVID-19 had HRQL below population norms on more than half of the SF-36 domains. Dutch-origin participants had significantly better HRQL than participants with a migration background. Participants with three or more COVID-19 high-risk comorbidities had worse HRQL than part participants with fewer comorbidities. Participants who completed the SF-36 when restrictive public health control measures applied reported less limitations in social and physical functioning and less impaired mental health than participants who completed the SF-36 when no restrictive measures applied. Conclusions: Twelve months after illness onset, persons with initial mild COVID-19 had HRQL within population norms, whereas persons with initial moderate or severe/critical COVID-19 still had impaired HRQL. Having a migration background and a higher number of COVID-19 high-risk comorbidities were associated with worse HRQL. Interestingly, HRQL was less impaired during periods when restrictive public health control measures were in place compared to periods without.
AB - Background: Currently, there is limited evidence about the long-term impact on physical, social and emotional functioning, i.e. health-related quality of life (HRQL) after mild or moderate COVID-19 not requiring hospitalization. We compared HRQL among persons with initial mild, moderate or severe/critical COVID-19 at 1 and 12 months following illness onset with Dutch population norms and investigated the impact of restrictive public health control measures on HRQL. Methods: RECoVERED, a prospective cohort study in Amsterdam, the Netherlands, enrolled adult participants after confirmed SARS-CoV-2 diagnosis. HRQL was assessed with the Medical Outcomes Study Short Form 36-item health survey (SF-36). SF-36 scores were converted to standard scores based on an age- and sex-matched representative reference sample of the Dutch population. Differences in HRQL over time were compared among persons with initial mild, moderate or severe/critical COVID-19 using mixed linear models adjusted for potential confounders. Results: By December 2021, 349 persons were enrolled of whom 269 completed at least one SF-36 form (77%). One month after illness onset, HRQL was significantly below population norms on all SF-36 domains except general health and bodily pain among persons with mild COVID-19. After 12 months, persons with mild COVID-19 had HRQL within population norms, whereas persons with moderate or severe/critical COVID-19 had HRQL below population norms on more than half of the SF-36 domains. Dutch-origin participants had significantly better HRQL than participants with a migration background. Participants with three or more COVID-19 high-risk comorbidities had worse HRQL than part participants with fewer comorbidities. Participants who completed the SF-36 when restrictive public health control measures applied reported less limitations in social and physical functioning and less impaired mental health than participants who completed the SF-36 when no restrictive measures applied. Conclusions: Twelve months after illness onset, persons with initial mild COVID-19 had HRQL within population norms, whereas persons with initial moderate or severe/critical COVID-19 still had impaired HRQL. Having a migration background and a higher number of COVID-19 high-risk comorbidities were associated with worse HRQL. Interestingly, HRQL was less impaired during periods when restrictive public health control measures were in place compared to periods without.
KW - Adult
KW - COVID-19
KW - COVID-19 Testing
KW - COVID-19/epidemiology
KW - Health-related quality of life
KW - Humans
KW - Prospective Studies
KW - Quality of Life/psychology
KW - Quality of life
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85141182621&partnerID=8YFLogxK
UR - https://pure.uva.nl/ws/files/113596229/12916_2022_2615_MOESM1_ESM.docx
U2 - https://doi.org/10.1186/s12916-022-02615-7
DO - https://doi.org/10.1186/s12916-022-02615-7
M3 - Article
C2 - 36324167
SN - 1464-2662
VL - 20
JO - BMC medicine
JF - BMC medicine
IS - 1
M1 - 422
ER -